CD8+ T cell-induced expression of tissue inhibitor of metalloproteinses-1 exacerbated osteoarthritis

International Journal of Molecular Sciences

Volumn 14, Issue 10, 2013, Pages 19951-19970

  Hsieh, Jeng Long ^a   Shiau, Ai Li ^b   Lee, Che Hsin ^c   Yang, Shiu Ju ^b   Lee, Bih O ^d   Jou, I Ming ^b   Wu, Chao Liang ^b   Chen, Shun Hua ^b   Shen, Po Chuan ^e  

^a CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e Tainan Hospital   (Taiwan)

Author keywords

CD8+ T cells; MMP 13; Osteoarthritis; TIMP 1; VEGF

Indexed keywords

CD8 ANTIGEN; COLLAGENASE 3; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR RECEPTOR 2; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION; ARTICLE; CARTILAGE DEGENERATION; CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNOCHEMISTRY; KNOCKOUT MOUSE; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; OSTEOARTHRITIS; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SPLEEN CELL; SYNOVIUM; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTERIOR CRUCIATE LIGAMENT; CARTILAGE; CD8-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; KNEE JOINT; MALE; MATRIX METALLOPROTEINASE 13; MICE; OSTEOARTHRITIS; SYNOVIAL MEMBRANE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84885352327     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms141019951     Document Type: Article

References (37)

1. Sowers, M. Epidemiology of risk factors for osteoarthritis: Systemic factors. Curr. Opin. Rheumatol. 2001, 13, 447-451.
2. Suri, S.; Gill, S.E.; Massena de Camin, S.; Wilson, D.; McWilliams, D.F.; Walsh, D.A. Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis. Ann. Rheum. Dis. 2007, 66, 1423-1428.
3. Walsh, D.A.; Bonnet, C.S.; Turner, E.L.; Wilson, D.; Situ, M.; McWilliams, D.F. Angiogenesis in the synovium and at the osteochondral junction in osteoarthritis. Osteoarthr. Cartil. 2007, 15, 743-751.
4. Fernandes, J.C.; Martel-Pelletier, J.; Pelletier, J.P. The role of cytokines in osteoarthritis pathophysiology. Biorheology 2002, 39, 237-246.
5. Berenbaum, F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthr. Cartil. 2013, 21, 16-21.
6. Goldring, M.B.; Otero, M. Inflammation in osteoarthritis. Curr. Opin. Rheumatol. 2011, 23, 471-478.
7. Kapoor, M.; Martel-Pelletier, J.; Lajeunesse, D.; Pelletier, J.P.; Fahmi, H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat. Rev. Rheumatol. 2011, 7, 33-42.
8. Sakkas, L.I.; Scanzello, C.; Johanson, N.; Burkholder, J.; Mitra, A.; Salgame, P.; Katsetos, C.D.; Platsoucas, C.D. T cells and T-cell cytokine transcripts in the synovial membrane in patients with osteoarthritis. Clin. Diagn. Lab. Immunol. 1998, 5, 430-437.
9. Muir, P.; Kelly, J.L.; Marvel, S.J.; Heinrich, D.A.; Schaefer, S.L.; Manley, P.A.; Tewari, K.; Singh, A.; Suresh, M.; Hao, Z.; et al. Lymphocyte populations in joint tissues from dogs with inflammatory stifle arthritis and associated degenerative cranial cruciate ligament rupture. Vet. Surg. 2011, 40, 753-761.
10. Kennedy, T.D.; Plater-Zyberk, C.; Partridge, T.A.; Woodrow, D.F.; Maini, R.N. Morphometric comparison of synovium from patients with osteoarthritis and rheumatoid arthritis. J. Clin. Pathol. 1988, 41, 847-852.
11. Lance, E.M.; Kimura, L.H.; Manibog, C.N. The expression of major histocompatibility antigens on human articular chondrocytes. Clin. Orthop. 1993, 291, 266-282.
12. Sakata, M.; Masuko-Hongo, K.; Nakamura, H.; Onuma, H.; Tsuruha, J.I.; Aoki, H.; Nishioka, K.; Kato, T. Osteoarthritic articular chondrocytes stimulate autologous T cell responses in vitro. Clin. Exp. Rheumatol. 2003, 21, 704-710.
13. Scanzello, C.R.; Umoh, E.; Pessler, F.; Diaz-Torne, C.; Miles, T.; Dicarlo, E.; Potter, H.G.; Mandl, L.; Marx, R.; Rodeo, S.; et al. Local cytokine profiles in knee osteoarthritis: Elevated synovial fluid interleukin-15 differentiates early from end-stage disease. Osteoarthr. Cartil. 2009, 17, 1040-1048.
14. Benito, M.J.; Veale, D.J.; FitzGerald, O.; van den Berg, W.B.; Bresnihan, B. Synovial tissue inflammation in early and late osteoarthritis. Ann. Rheum. Dis. 2005, 64, 1263-1267.
15. Shen, P.C.; Wu, C.L.; Jou, I.M.; Lee, C.H.; Juan, H.Y.; Lee, P.J.; Chen, S.H.; Hsieh, J.L. T helper cells promote disease progression of osteoarthritis by inducing macrophage inflammatory protein-1. Osteoarthr. Cartil. 2011, 19, 728-736.
16. Relic, B.; Guicheux, J.; Mezin, F.; Lubberts, E.; Togninalli, D.; Garcia, I.; van den Berg, W.B.; Guerne, P.A. IL-4 and IL-13, but not IL-10, protect human synoviocytes from apoptosis. J. Immunol. 2001, 166, 2775-2782.
17. Comabella, M.; Julià, E.; Tintoré, M.; Brieva, L.; Téllez, N.; Río, J.; López, C.; Rovira, A.; Montalban, X. Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon ß-1b in patients with progressive multiple sclerosis. J. Neurol. 2008, 255, 1136-1141.
18. Rai, M.F.; Graeve, T.; Twardziok, S.; Schmidt M.F. Evidence for regulated interleukin-4 expression in chondrocyte-scaffolds under in vitro inflammatory conditions. PLoS One 2011, 6, e25749.
19. Gomez, D.E.; Alonso, D.F.; Yoshiji, H.; Thorgeirsson, U.P. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions. Eur. J. Cell Biol. 1997, 74, 111-122.
20. Kevorkian, L.; Young, D.A.; Darrah, C.; Donell, S.T.; Shepstone, L.; Porter, S.; Brockbank, S.M.; Edwards, D.R.; Parker, A.E.; Clark, I.M. Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum. 2004, 50, 131-141.
21. Leonardi, A.; Cortivo, R.; Fregona, I.; Plebani, M.; Secchi, A.G.; Abatangelo, G. Effects of Th2 cytokines on expression of collagen, MMP-1, and TIMP-1 in conjunctival fibroblasts. Invest. Ophthalmol. Vis. Sci. 2003, 44, 183-189.
22. + T cells in corneas of ocularly infected mice. Virology 2010, 399, 11-22.
23. Clark, R.T.; Nance, J.P.; Noor, S.; Wilson, E.H. T-cell production of matrix metalloproteinases and inhibition of parasite clearance by TIMP-1 during chronic Toxoplasma infection in the brain. Am. Soc. Neurochem. 2011, 3, e00049.
24. Suidan, G.L.; Dickerson, J.W.; Chen, Y.; McDole, J.R.; Tripathi, P.; Pirko, I.; Seroogy, K.B.; Johnson, A.J. CD8 T cell-initiated vascular endothelial growth factor expression promotes central nervous system vascular permeability under neuroinflammatory conditions. J. Immunol. 2010, 184, 1031-1040.
25. Nakamura, H.; Tanaka, M.; Masuko-Hongo, K.; Yudoh, K.; Kato, T.; Beppu, M.; Nishioka, K. Enhanced production of MMP-1, MMP-3, MMP-13, and RANTES by interaction of chondrocytes with autologous T cells. Rheumatol. Int. 2006, 26, 984-990.
26. Fransès, R.E.; McWilliams, D.F.; Mapp, P.I.; Walsh, D.A. Osteochondral angiogenesis and increased protease inhibitor expression in OA. Osteoarthr. Cartil. 2010, 18, 563-571.
27. Pufe, T.; Harde, V.; Petersen, W.; Goldring, M.B.; Tillmann, B.; Mentlein, R. Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes. J. Pathol. 2004, 202, 367-374.
28. Kim, K.S.; Choi, H.M.; Lee, Y.A.; Choi, I.A.; Lee, S.H.; Hong, S.J.; Yang, H.I.; Yoo, M.C. Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis. Rheumatol. Int. 2011, 31, 543-547.
29. Jung, K.K.; Liu, X.W.; Chirco, R.; Fridman, R.; Kim, H.R. Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein. EMBO 2006, 25, 3934-3942.
30. Stetler-Stevenson, W.G. Tissue inhibitors of metalloproteinases in cell signaling: Metalloproteinase-independent biological activities. Sci. Signal. 2008, 1, doi:10.1126/scisignal.127re6.
31. Hill, C.L.; Seo, G.S.; Gale, D.; Totterman, S.; Gale, M.E.; Felson, D.T. Cruciate ligament integrity in osteoarthritis of the knee. Arthritis Rheum. 2005, 52, 794-799.
32. Catterall, J.B.; Stabler, T.V.; Flannery, C.R.; Kraus, V.B. Changes in serum and synovial fluid biomarkers after acute injury (NCT00332254). Arthritis Res. Ther. 2010, 12, doi:10.1186/ar3216.
33. Glasson, S.S.; Blanchet, T.J.; Morris, E.A. The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse. Osteoarthr. Cartil. 2007, 15, 1061-1069.
34. Kamekura, S.; Hoshi, K.; Shimoaka, T.; Chung, U.; Chikuda, H.; Yamada, T.; Uchida, M.; Ogata, N.; Seichi, A.; Nakamura, K.; et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthr. Cartil. 2005, 13, 632-641.
35. Hsieh, J.L.; Shen, P.C.; Shiau, A.L.; Jou, I.M.; Lee, C.H.; Teo, M.L.; Wang, C.R.; Chao, J.; Chao, L.; Wu, C.L. Adenovirus-mediated kallistatin gene transfer ameliorates disease progression in a rat model of osteoarthritis induced by anterior cruciate ligament transection. Hum. Gene Ther. 2009, 20, 147-158.
36. Mankin, H.J.; Dorfman, H.; Lippiello, L.; Zarins, A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J. Bone Joint Surg. Am. 1971, 53, 523-537.
37. Yoshimi, T.; Kikuchi, T.; Obara, T.; Yamaguchi, T.; Sakakibara, Y.; Itoh, H.; Iwata, H.; Miura, T. Effects of high-molecular-weight sodium hyaluronate on experimental osteoarthrosis induced by the resection of rabbit anterior cruciate ligament. Clin. Orthop. Relat. Res. 1994, 298, 296-304.